A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study

K. Yamazaki, H. Yasui, K. Yamaguchi, Y. Kagawa, Y. Kuboki, T. Yoshino, M. Gamoh, Y. Komatsu, H. Satake, M. Goto, H. Tanioka, E. Oki, M. Kotaka, A. Makiyama, T. Denda, J. Soeda, K. Shibya, M. Iwata, K. Oba, T. Kato

研究成果: Contribution to journalArticle

76 被引用数 (Scopus)
本文言語英語
ページ(範囲)v71
ジャーナルAnnals of oncology : official journal of the European Society for Medical Oncology
29
DOI
出版ステータス出版済み - 6 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

引用スタイル